BioSpace News Archive

Drug Development

Study: Survivors of Severe COVID-19 at Higher Mortality Risk and More Research

Research continues to reveal how COVID-19 affects different people with different health issues, both short-term and long-term.

December 2, 2021
·
5 min read
·
Mark Terry
Drug Development

Research Roundup: A Potential Cause of Alzheimer’s Disease and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

December 2, 2021
·
5 min read
·
Mark Terry
Drug Development

BeyondSpring is Going Back to the Drawing Board with CIN Prevention Asset

In the CRL, the FDA indicated that the single registrational trial (106 Phase III) did not provide sufficient proof of efficacy to demonstrate benefit.

December 2, 2021
·
2 min read
·
Heather McKenzie
Business

Astellas Hopes to Improve Gene Therapy Safety with $1.6 Billion Dyno Deal

With this new collaboration, Astellas will take advantage of Dynos’ next-gen AAV vectors to deliver its gene therapy.

December 2, 2021
·
2 min read
·
Kate Goodwin
Pharm Country

GSK Shares Positive Omicron Update, New Oxford Partnership

GlaxoSmithKline said early research shows its monoclonal antibody is demonstrating efficacy against the newest strain of COVID-19.

December 2, 2021
·
3 min read
·
Alex Keown
Drug Development

Amgen’s Otezla Shines Again in Psoriasis

The Phase III DISCREET study evaluated the efficacy of Otezla in adults who have been diagnosed with moderate to severe plaque psoriasis and genital psoriasis.

December 2, 2021
·
2 min read
·
Vanessa Doctor, RN
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104Bioavailability of GTX-104 compares favorably with the oral formulation of nimodipine; full PK study expected to report out as planned in H1’22

Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced positive results for GTX-104 based on its interim analysis of the first 20 of 50 normal healthy subjects in its pivotal pharmacokinetic (PK) bridging study.

December 2, 2021
·
10 min read
Biotech Beach

Recro to Present at Stephens Annual Investment ConferenceFireside Chat Webcast Available

Recro Pharma, Inc. today announced that its chief executive officer, David Enloe, will participate in a fireside chat as part of the Stephens Annual Investment Conference | NASH2021.

December 2, 2021
·
2 min read
Bio NC

RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announces the publication of a new study entitled “Helicobacter pylori Eradication by Low-Dose Rifabutin Triple Therapy,

December 2, 2021
·
13 min read
CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal

CollPlant Biotechnologies today announced the publication of an article in the Plastic and Reconstructive Surgery journal.

December 2, 2021
·
6 min read